Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT00036426. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of FavId (Tumor-Specific Idiotype-KLH) and Soluble GM-CSF Immunotherapy in Patients With Stable or Progressive Grade 1 and 2 Follicular B-Cell Lymphomas
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine if an idiotype vaccine, made from a patient's lymphoma that has returned after chemotherapy and/or rituximab, would be able to shrink their tumor.
Study identification
- NCT ID
- NCT00036426
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2001 (Type not available)
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
Started 2001
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Stevens Cancer Center | La Jolla | California | 92037 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| Tower Hematology Oncology Medical Group | Los Angeles | California | 90048 | — |
| Oncology Associates of San Diego | San Diego | California | 92123 | — |
| Medical Group of North County | Vista | California | 92083 | — |
| University of Florida, Jacksonville | Jacksonville | Florida | 32209 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| New York Hospital - Cornell Medical Center | New York | New York | 10021 | — |
| New York Medical College - Our Lady of Mercy Medical Center, Comprehensive Cancer Center | The Bronx | New York | 10466 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45219 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00036426, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00036426 live on ClinicalTrials.gov.